Clinical Trial Update: Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This document reports an update on a Phase 1/2 clinical trial evaluating treatment for relapsed or refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED